Skip to content
MedsAcross

Medicine

Miglitol 25 mg tablet

Miglitol · Oral
Available on requestPrescription onlyUS FDAGeneric name

Miglitol 25 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).

Key facts

Active ingredient (INN)
Miglitol
Brand
Sold under the generic name
Strength
25 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 30 tablets, 60 tablets and 2 more
Manufacturers
Proficient RxWestminster Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A10BF02 Miglitol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 January 2021
Identifiers
RxCUI 205329, 205330, 205331DailyMed set ID b8da2015-d254-2425-e053-2995a90acf0e, f16ecb50-e54e-43e1-8789-eaf5bc94f332NDC 69367-303, 71205-935Application ANDA203965

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, coated in 1 bottle71205-935-00Proficient Rx1 March 2021
30 tablet, coated in 1 bottle71205-935-30Proficient Rx1 March 2021
60 tablet, coated in 1 bottle71205-935-60Proficient Rx1 March 2021
90 tablet, coated in 1 bottle71205-935-90Proficient Rx1 March 2021
100 tablet, coated in 1 bottle69367-303-01Westminster Pharmaceuticals15 January 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 18 December 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Miglitol

Clinical summary

Miglitol is an alpha-glucosidase inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets for oral use. MedsAcross supplies Miglitol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Miglitol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Miglitol 25 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.